How should a neck mass suspected to be lymphoma be evaluated and managed?

Evaluation and Management of Lymphoma Presenting as Neck Mass

A neck mass suspected to be lymphoma requires immediate risk stratification, contrast-enhanced CT imaging, and tissue diagnosis via fine-needle aspiration (FNA) or core needle biopsy—with core biopsy preferred when lymphoma is strongly suspected based on clinical features.

Initial Risk Assessment

First, identify if the patient is at increased risk for malignancy using these specific criteria 1:

High-Risk Historical Features:

• Mass present ≥2 weeks without significant fluctuation or uncertain duration
• No history of recent infection (absence of infectious etiology makes malignancy more likely)
• Age >40 years
• Tobacco and/or alcohol use
• Constitutional symptoms: unexplained weight loss, night sweats, fever

High-Risk Physical Examination Features (≥1 present):

• Size >1.5 cm
• Firm consistency (lymphoma nodes are typically firm, rubbery, and non-tender)
• Fixation to adjacent tissues (reduced mobility)
• Ulceration of overlying skin
• Multiple enlarged nodes in different cervical regions
• Associated hepatosplenomegaly

Additional Red Flags Suggesting Head/Neck Primary:

• Pharyngitis, dysphagia, or oral/oropharyngeal ulcers
• Ipsilateral otalgia with normal ear exam
• Recent voice change
• Ipsilateral hearing loss or nasal obstruction with epistaxis 2, 1

Critical Pitfall to Avoid

Do NOT prescribe antibiotics unless there are clear signs of bacterial infection (warmth, erythema, localized tenderness, fever) 1. Empiric antibiotics delay diagnosis of malignancy and are inappropriate for most adult neck masses, which are predominantly neoplastic rather than infectious.

Diagnostic Algorithm for High-Risk Patients

Step 1: Imaging (Strong Recommendation)

Order contrast-enhanced CT of the neck (or MRI with contrast if CT contraindicated) 1. This is a strong recommendation from the 2017 AAO-HNS guidelines and should be done for all patients deemed at increased risk for malignancy.

• CT provides staging information and assesses involvement of vital structures
• Identifies additional nodal disease and extranodal involvement
• Guides subsequent biopsy planning

Step 2: Tissue Diagnosis

When lymphoma is strongly suspected clinically, proceed directly to core needle biopsy rather than FNA 1. This is the most important distinction for lymphoma evaluation:

• Core needle biopsy sensitivity for lymphoma: 92%
• FNA sensitivity for lymphoma: only 74% 1
• Core biopsy provides tissue architecture necessary for lymphoma subtyping and WHO classification
• Ultrasound-guided core biopsy has 95% adequacy rate and 96% accuracy for malignancy detection 1

If FNA is performed first (when diagnosis uncertain):

• If inadequate or indeterminate results, proceed to repeat FNA with ultrasound guidance before open biopsy 1
• Ultrasound guidance increases specimen adequacy, especially for cystic/necrotic masses
• On-site cytopathologist evaluation reduces inadequacy rates
• If cytology suggests lymphoma, immediately proceed to core biopsy for definitive subtyping

Step 3: Targeted Physical Examination

Perform or refer for visualization of larynx, base of tongue, and pharynx to exclude head and neck squamous cell carcinoma as the primary source 1. This is essential before proceeding to open biopsy.

Step 4: If Diagnosis Still Uncertain

Examination under anesthesia with panendoscopy before open biopsy 1. This identifies occult primary sites in the upper aerodigestive tract that could be the source of metastatic disease.

Special Considerations for Lymphoma

Cystic Neck Masses

Do not assume cystic masses are benign 1. Continue evaluation until diagnosis is obtained, as cystic degeneration can occur in lymphoma and metastatic disease. Direct biopsy to solid components using ultrasound guidance.

Tissue Handling for Suspected Lymphoma

When core biopsy is performed for suspected lymphoma 3:

• Obtain 8-9 cores from different parts of the mass
• Systematically freeze 2 cores for immunohistochemistry and molecular studies
• This approach achieves 98% diagnostic yield for lymphoma typing and 86% for complete subtyping/grading 3

Ancillary Testing

Once lymphoma is suspected or confirmed, obtain 1:

• Complete blood count with differential
• Comprehensive metabolic panel (including LDH)
• HIV serology
• Hepatitis B and C serology
• Consider HTLV-1 serology if clinical features suggest adult T-cell leukemia/lymphoma 4

Key Strength of Evidence

The 2017 AAO-HNS Clinical Practice Guidelines [2-1] provide the framework for this algorithmic approach, with Grade C evidence (observational studies) supporting risk stratification criteria and strong recommendations for CT imaging and FNA over open biopsy. The critical modification for suspected lymphoma—preferring core biopsy over FNA—is supported by meta-analysis data showing significantly higher sensitivity 1.

The emphasis on avoiding empiric antibiotics, obtaining adequate imaging before tissue diagnosis, and using core biopsy for suspected lymphoma represents the most evidence-based approach to prevent diagnostic delays and optimize outcomes through earlier, accurate diagnosis.